Patents Assigned to SingletO2 Therapeutics LLC
  • Singlet oxygen generating device for selective destruction of pathogens
    Patent number: 11918823
    Abstract: A device for generating singlet oxygen is provided. The device has a sensitizer that converts triplet oxygen to single oxygen upon exposure to light. The device is configured to keep the sensitizer from contacting external fluids.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: March 5, 2024
    Assignees: Research Foundation of the City University of New York, SingletO2 Therapeutics LLC
    Inventors: Alan M. Lyons, Alexander Greer, QianFeng Xu